Shandong Buchang Pharmaceuticals Co Ltd (603858) — Cash Flow Quality Index
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Cash Flow Quality Index of -0.60x as of September 2025. Operating cash flow of CN¥-145.26 Million is below net income of CN¥240.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Shandong Buchang Pharmaceuticals Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Buchang Pharmaceuticals Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for Shandong Buchang Pharmaceuticals Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Shandong Buchang Pharmaceuticals Co Ltd (603858) cash flow conversion.
Annual Cash Flow Quality Index for Shandong Buchang Pharmaceuticals Co Ltd (2012–2023)
Year-by-year earnings quality comparison for Shandong Buchang Pharmaceuticals Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.08x | CN¥-164.26 Million | CN¥151.87 Million | ▼ -201.2% |
| 2021 | 1.07x | CN¥1.32 Billion | CN¥1.24 Billion | ▲ +0.6% |
| 2020 | 1.06x | CN¥1.96 Billion | CN¥1.84 Billion | ▼ -20.4% |
| 2019 | 1.34x | CN¥2.62 Billion | CN¥1.96 Billion | ▲ +24.2% |
| 2018 | 1.08x | CN¥2.05 Billion | CN¥1.91 Billion | ▼ -10.2% |
| 2017 | 1.20x | CN¥1.96 Billion | CN¥1.64 Billion | ▲ +27.0% |
| 2016 | 0.94x | CN¥1.67 Billion | CN¥1.77 Billion | ▲ +57.1% |
| 2015 | 0.60x | CN¥2.12 Billion | CN¥3.53 Billion | ▼ -49.1% |
| 2014 | 1.18x | CN¥1.78 Billion | CN¥1.51 Billion | ▲ +42.8% |
| 2013 | 0.83x | CN¥1.11 Billion | CN¥1.35 Billion | ▼ -23.3% |
| 2012 | 1.08x | CN¥1.35 Billion | CN¥1.25 Billion | — |